These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37337174)

  • 1. An effectiveness and economic analyses of tricalcium phosphate combined with iliac bone graft versus RhBMP-2 in single-level XLIF surgery in Thailand.
    Boonsirikamchai W; Phisalprapa P; Kositamongkol C; Korwutthikulrangsri E; Ruangchainikom M; Sutipornpalangkul W
    BMC Musculoskelet Disord; 2023 Jun; 24(1):503. PubMed ID: 37337174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness and Clinical Outcomes of Lateral Lumbar Interbody Fusion With Tricalcium Phosphate and Iliac Bone Graft Compared With Posterior Lumbar Interbody Fusion With Local Bone Graft in Single-Level Lumbar Spinal Fusion Surgery in Thailand.
    Tirawanish P; Phisalprapa P; Kositamongkol C; Korwutthikulrangsri E; Ruangchainikom M; Sutipornpalangkul W
    Int J Spine Surg; 2024 Jun; ():. PubMed ID: 38886013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.
    Parker RM; Malham GM
    Eur Spine J; 2017 Mar; 26(3):754-763. PubMed ID: 28028645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
    Dai LY; Jiang LS
    Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose.
    Pelletier MH; Oliver RA; Christou C; Yu Y; Bertollo N; Irie H; Walsh WR
    Spine J; 2014 Aug; 14(8):1758-68. PubMed ID: 24486479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective, Randomized, Multicenter Study Comparing Silicated Calcium Phosphate versus BMP-2 Synthetic Bone Graft in Posterolateral Instrumented Lumbar Fusion for Degenerative Spinal Disorders.
    Coughlan M; Davies M; Mostert AK; Nanda D; Willems PC; Rosenberg G; Ferch R
    Spine (Phila Pa 1976); 2018 Aug; 43(15):E860-E868. PubMed ID: 29652784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility Analysis of Anterior Cervical Discectomy and Fusion for Cervical Spondylosis Patients Comparing Polyetheretherketone Versus Tricortical Iliac Crest Bone Graft.
    Hajeeyeh M; Wilartratsami S; Phisalprapa P; Piyapromdee U; Sornsa-Ard T; Kositamongkol C; Vamvanij V; Luksanapruksa P
    Clin Spine Surg; 2023 Oct; 36(8):E353-E361. PubMed ID: 37296495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis.
    Lerner T; Bullmann V; Schulte TL; Schneider M; Liljenqvist U
    Eur Spine J; 2009 Feb; 18(2):170-9. PubMed ID: 19082847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
    Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative and long-term clinical outcomes for bone morphogenetic protein versus iliac crest bone graft for lumbar fusion in degenerative disk disease: systematic review with meta-analysis.
    Noshchenko A; Hoffecker L; Lindley EM; Burger EL; Cain CM; Patel VV
    J Spinal Disord Tech; 2014 May; 27(3):117-35. PubMed ID: 24945290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial.
    Cho JH; Lee JH; Yeom JS; Chang BS; Yang JJ; Koo KH; Hwang CJ; Lee KB; Kim HJ; Lee CK; Kim H; Suk KS; Nam WD; Han J
    Spine J; 2017 Dec; 17(12):1866-1874. PubMed ID: 28652196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of beta-tricalcium phosphate and bone marrow aspirate as a bone graft substitute in posterior lumbar interbody fusion.
    Thaler M; Lechner R; Gstöttner M; Kobel C; Bach C
    Eur Spine J; 2013 May; 22(5):1173-82. PubMed ID: 23073745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Recombinant Human Bone Morphogenetic Protein-2 With Iliac Crest Bone Graft Instead of Iliac Crest Bone Graft Alone in Lumbar Spondylolysis.
    Meng H; Gao Y; Zhao G; Sun T; Li F
    Clin Spine Surg; 2022 Mar; 35(2):E314-E319. PubMed ID: 34654776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study.
    Taghavi CE; Lee KB; Keorochana G; Tzeng ST; Yoo JH; Wang JC
    Spine (Phila Pa 1976); 2010 May; 35(11):1144-50. PubMed ID: 20139805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.